Using American Type Culture Collection Cell Lines to Evaluate Interlaboratory Variables for Estrogen Receptor and Human Epidermal Growth Factor Receptor 2 Immunostaining.
AuthorWitt, Benjamin L
Ambaye, Abiy B
Booth, Christine N
Russell, Donna K
Staats, Paul N
Souers, Rhona J
Kurtycz, Daniel Fi
JournalArchives of Pathology & Laboratory Medicine
MetadataShow full item record
AbstractOBJECTIVE: To explore advantages of using cell lines with known antigenicity as a validation method. DESIGN: Five American Type Culture Collection (ATCC) cell lines with known negative, low positive, and moderate to strong estrogen receptor (ER) expression as well as negative, equivocal, and positive human epidermal growth factor receptor 2 (HER2) expression were cultured and made into cell blocks. One block from each cell line was fixed in formalin and another in ethanol before cell block preparation. Two sets of paired unstained slides from each block were sent to 10 different laboratories for HER2 and ER staining to be stained on runs from different days according to each laboratory's defined protocol. RESULTS: The 10 study participants evaluated 40 slides in a blinded fashion. For ER expression, all 80 interpretations for the ER strong and moderate positive cell lines had the target ER-positive result and 74 of 80 ER-negative cell lines (92.5%) had agreement with the intended negative result. The ER low positive cell line showed varied but positive expression, among all observers. The HER2 (3+)-positive cell lines yielded a target interpretation of 3+ in 65 of 80 (81.2%). For the HER2-negative cell line 69 of 78 interpretations (88.5%) were consistent with the target response (0 or 1+). No significant variation was observed between the ethanol- and non-ethanol-exposed cell lines, or between runs by the same laboratory. Variation from target results clustered within laboratories. CONCLUSIONS: This study indicates that variability between laboratories can be identified by using cell lines for quantitative or semiquantitative immunohistochemistry when using cultured cell lines of known antigenicity. These cell lines could potentially play a role in aiding anatomic pathology laboratories in validating immunohistochemistry tests for formalin- and ethanol-fixed tissues.
Rights/Terms© 2022 College of American Pathologists.
Identifier to cite or link to this itemhttp://hdl.handle.net/10713/19051
- Interlaboratory comparison of immunohistochemical testing for HER2: results of the 2004 and 2005 College of American Pathologists HER2 Immunohistochemistry Tissue Microarray Survey.
- Authors: Fitzgibbons PL, Murphy DA, Dorfman DM, Roche PC, Tubbs RR, Immunohistochemistry Committee, College of American Pathologists
- Issue date: 2006 Oct
- Estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 expression in breast cancer FNA cell blocks and paired histologic specimens: A large retrospective study.
- Authors: Vohra P, Buelow B, Chen YY, Serrano M, Vohra MS, Berry A, Ljung BM
- Issue date: 2016 Nov
- Quality assurance for detection of estrogen and progesterone receptors by immunohistochemistry in Austrian pathology laboratories.
- Authors: Regitnig P, Reiner A, Dinges HP, Höfler G, Müller-Holzner E, Lax SF, Obrist P, Rudas M, Quehenberger F
- Issue date: 2002 Oct
- Assessment of interlaboratory variation in the immunohistochemical determination of estrogen receptor status using a breast cancer tissue microarray.
- Authors: Parker RL, Huntsman DG, Lesack DW, Cupples JB, Grant DR, Akbari M, Gilks CB
- Issue date: 2002 May
- Quantitative Assessment of Immunohistochemistry Laboratory Performance by Measuring Analytic Response Curves and Limits of Detection.
- Authors: Sompuram SR, Vani K, Schaedle AK, Balasubramanian A, Bogen SA
- Issue date: 2018 Jul